Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. 1998

G S Ogg, and X Jin, and S Bonhoeffer, and P R Dunbar, and M A Nowak, and S Monard, and J P Segal, and Y Cao, and S L Rowland-Jones, and V Cerundolo, and A Hurley, and M Markowitz, and D D Ho, and D F Nixon, and A J McMichael
Institute of Molecular Medicine, Nuffield Department of Medicine, Oxford OX3 9DS, UK.

Although cytotoxic T lymphocytes (CTLs) are thought to be involved in the control of human immunodeficiency virus-type 1 (HIV-1) infection, it has not been possible to demonstrate a direct relation between CTL activity and plasma RNA viral load. Human leukocyte antigen-peptide tetrameric complexes offer a specific means to directly quantitate circulating CTLs ex vivo. With the use of the tetrameric complexes, a significant inverse correlation was observed between HIV-specific CTL frequency and plasma RNA viral load. In contrast, no significant association was detected between the clearance rate of productively infected cells and frequency of HIV-specific CTLs. These data are consistent with a significant role for HIV-specific CTLs in the control of HIV infection and suggest a considerable cytopathic effect of the virus in vivo.

UI MeSH Term Description Entries
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D003588 Cytopathogenic Effect, Viral Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses. Cytopathic Effect, Viral,Viral Cytopathogenic Effect,Cytopathic Effects, Viral,Cytopathogenic Effects, Viral,Effect, Viral Cytopathic,Effect, Viral Cytopathogenic,Effects, Viral Cytopathic,Effects, Viral Cytopathogenic,Viral Cytopathic Effect,Viral Cytopathic Effects,Viral Cytopathogenic Effects
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D004396 Coloring Agents Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. Coloring Agent,Dye,Dyes,Organic Pigment,Stain,Stains,Tissue Stain,Tissue Stains,Organic Pigments,Pigments, Inorganic,Agent, Coloring,Inorganic Pigments,Pigment, Organic,Pigments, Organic,Stain, Tissue,Stains, Tissue
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic
D014766 Viremia The presence of viruses in the blood. Viremias

Related Publications

G S Ogg, and X Jin, and S Bonhoeffer, and P R Dunbar, and M A Nowak, and S Monard, and J P Segal, and Y Cao, and S L Rowland-Jones, and V Cerundolo, and A Hurley, and M Markowitz, and D D Ho, and D F Nixon, and A J McMichael
January 1989, Research in immunology,
G S Ogg, and X Jin, and S Bonhoeffer, and P R Dunbar, and M A Nowak, and S Monard, and J P Segal, and Y Cao, and S L Rowland-Jones, and V Cerundolo, and A Hurley, and M Markowitz, and D D Ho, and D F Nixon, and A J McMichael
November 1996, Journal of immunology (Baltimore, Md. : 1950),
G S Ogg, and X Jin, and S Bonhoeffer, and P R Dunbar, and M A Nowak, and S Monard, and J P Segal, and Y Cao, and S L Rowland-Jones, and V Cerundolo, and A Hurley, and M Markowitz, and D D Ho, and D F Nixon, and A J McMichael
September 1994, Immunology,
G S Ogg, and X Jin, and S Bonhoeffer, and P R Dunbar, and M A Nowak, and S Monard, and J P Segal, and Y Cao, and S L Rowland-Jones, and V Cerundolo, and A Hurley, and M Markowitz, and D D Ho, and D F Nixon, and A J McMichael
January 1997, Springer seminars in immunopathology,
G S Ogg, and X Jin, and S Bonhoeffer, and P R Dunbar, and M A Nowak, and S Monard, and J P Segal, and Y Cao, and S L Rowland-Jones, and V Cerundolo, and A Hurley, and M Markowitz, and D D Ho, and D F Nixon, and A J McMichael
November 1993, AIDS research and human retroviruses,
G S Ogg, and X Jin, and S Bonhoeffer, and P R Dunbar, and M A Nowak, and S Monard, and J P Segal, and Y Cao, and S L Rowland-Jones, and V Cerundolo, and A Hurley, and M Markowitz, and D D Ho, and D F Nixon, and A J McMichael
September 2002, Clinics in laboratory medicine,
G S Ogg, and X Jin, and S Bonhoeffer, and P R Dunbar, and M A Nowak, and S Monard, and J P Segal, and Y Cao, and S L Rowland-Jones, and V Cerundolo, and A Hurley, and M Markowitz, and D D Ho, and D F Nixon, and A J McMichael
December 1999, Clinical science (London, England : 1979),
G S Ogg, and X Jin, and S Bonhoeffer, and P R Dunbar, and M A Nowak, and S Monard, and J P Segal, and Y Cao, and S L Rowland-Jones, and V Cerundolo, and A Hurley, and M Markowitz, and D D Ho, and D F Nixon, and A J McMichael
December 1996, Proceedings of the National Academy of Sciences of the United States of America,
G S Ogg, and X Jin, and S Bonhoeffer, and P R Dunbar, and M A Nowak, and S Monard, and J P Segal, and Y Cao, and S L Rowland-Jones, and V Cerundolo, and A Hurley, and M Markowitz, and D D Ho, and D F Nixon, and A J McMichael
January 1989, Research in immunology,
G S Ogg, and X Jin, and S Bonhoeffer, and P R Dunbar, and M A Nowak, and S Monard, and J P Segal, and Y Cao, and S L Rowland-Jones, and V Cerundolo, and A Hurley, and M Markowitz, and D D Ho, and D F Nixon, and A J McMichael
January 2005, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!